Skip to main content

Advertisement

ADVERTISEMENT

Commentary

Commentary
06/28/2019
Robin Lloyd, chief commercial officer, Health Fidelity, discusses the latest trends and policy changes impacting ACOs and reflects on new federal policies, highlighting future opportunities in value-based care.
Robin Lloyd, chief commercial officer, Health Fidelity, discusses the latest trends and policy changes impacting ACOs and reflects on new federal policies, highlighting future opportunities in value-based care.
Robin Lloyd, chief commercial...
06/28/2019
First Report Managed Care
Commentary
05/30/2019
While specialty drugs and regulatory changes continue to dominate the health care conversation, First Report Managed Care's expert, Russ J Spjut, PharmD, examines the development of oral semaglutides and their future role in treating type 2...
While specialty drugs and regulatory changes continue to dominate the health care conversation, First Report Managed Care's expert, Russ J Spjut, PharmD, examines the development of oral semaglutides and their future role in treating type 2...
While specialty drugs and...
05/30/2019
First Report Managed Care
Commentary
03/20/2019
In a podcast hosted on Veterans Health Today, Steven Lieberman, MD, acting principal deputy under secretary for health at the Veterans Health Administration, explained the history of wait times within the VA and discusses how they have...
In a podcast hosted on Veterans Health Today, Steven Lieberman, MD, acting principal deputy under secretary for health at the Veterans Health Administration, explained the history of wait times within the VA and discusses how they have...
In a podcast hosted on Veterans...
03/20/2019
First Report Managed Care

Advertisement

Commentary
03/19/2019
We recently reported on the various federal and state initiatives to combat rising drug prices. Now our panel of experts analyze HHS's new measure to curb PBM rebate regulations in order to offset high prices.
We recently reported on the various federal and state initiatives to combat rising drug prices. Now our panel of experts analyze HHS's new measure to curb PBM rebate regulations in order to offset high prices.
We recently reported on the...
03/19/2019
First Report Managed Care
Commentary
03/15/2019
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, reflects on the recent senate committee hearing where CEOs of the seven top pharma companies were questioned about drug...
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, reflects on the recent senate committee hearing where CEOs of the seven top pharma companies were questioned about drug...
Peter Pitts, former associate...
03/15/2019
First Report Managed Care
Commentary
02/13/2019
As drug prices continue to be a highly contested topic, First Report Managed Care’s expert Russ J. Spjut, PharmD, offers his own commentary on drug rebates and their contribution to rising costs.
As drug prices continue to be a highly contested topic, First Report Managed Care’s expert Russ J. Spjut, PharmD, offers his own commentary on drug rebates and their contribution to rising costs.
As drug prices continue to be a...
02/13/2019
First Report Managed Care

Advertisement

Commentary
01/31/2019
While the nation undergoes turbulent times surrounding illegal immigration, New York City and California are offering plans to cover undocumented immigrants. First Report Managed Care reached out to its panel of experts for their take on...
While the nation undergoes turbulent times surrounding illegal immigration, New York City and California are offering plans to cover undocumented immigrants. First Report Managed Care reached out to its panel of experts for their take on...
While the nation undergoes...
01/31/2019
First Report Managed Care
Commentary
01/25/2019
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses recent agreements finalized by the White House, United States, Mexico, and Canada, and he explains why this new...
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses recent agreements finalized by the White House, United States, Mexico, and Canada, and he explains why this new...
Peter Pitts, former associate...
01/25/2019
First Report Managed Care
Commentary
01/22/2019
In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-term risk, and genetic cholesterol problems...
In the second installment of this series, Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, discusses lifestyle risk, long-term risk, and genetic cholesterol problems...
In the second installment of...
01/22/2019
First Report Managed Care

Advertisement

Commentary
01/15/2019
Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, explains how patient outcomes impact primary and secondary prevention and related treatment costs.
Amit Khera, MD, director of Preventive Cardiology and a Professor of Medicine at UT-Southwestern Medical Center in Dallas, explains how patient outcomes impact primary and secondary prevention and related treatment costs.
Amit Khera, MD, director of...
01/15/2019
First Report Managed Care

Advertisement